The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
MIRA Pharmaceuticals, Inc.(NASDAQ:MIRA)


MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitiv...
Website: https://www.mirapharmaceuticals.com/
Founded: 2020
IPO Price: $7 (Aug 03, 2023)
CEO: Erez Aminov
Sector: ...
Industry: Pharmaceuticals
Share this website to your friends
MIRA Pharmaceuticals . Op Cashflow Per Share ttm
MIRA Pharmaceuticals . Free Cashflow Per Share ttm
MIRA Pharmaceuticals . Cash Per Share ttm
MIRA Pharmaceuticals . (GAAP) P/E ratio ttm
MIRA Pharmaceuticals . P/B ratio ttm
No extra charts and metrics for this ticker.